IBD Research – ETAP-Labs and Kisolite Corp enter into partnership.
Better than any certification, at ETAP-Lab we believe that customer recognition is the ultimate goal. We’re proud to announce our strategic partnership with Kisolite Corp, a leader in innovative therapeutic solutions. Together, we’re advancing in vivo studies for their treatment targeting Inflammatory Bowel Disease (IBD).
Our dedication to building lasting relationships goes beyond expertise. Our flexible and human-sized organization offers personalized support, ensuring clients feel empowered throughout the research process.
Ready to collaborate on your next drug efficacy study? Contact us today to explore how ETAP-Lab can contribute to your success!
More about the partnership with Kisolite: https://www.kisolite.com/partnerships
